After devolution of the application for emergency use, the future of 10 million doses of the vaccine against Covid-19 Sputnik V, produced by the Russian institute Gamaleya, which are on their way to Brazil is uncertain.
The request was made by União Química, a pharmaceutical industry that intends to distribute the immunizer in Brazil. The company expects to receive Russia 600 doses of Sputnik V still in January, followed by 3,4 million doses in February and 6 million doses in March. According to a report by Valor Econômico, the intention is to distribute in Brazil, still in 2021, 150 million doses of the vaccine.